| Diagnostic utility of molecular and imaging biomarkers in cytological indeterminate thyroid nodules EJ de Koster, LF de Geus-Oei, OM Dekkers, I van Engen-van Grunsven, ... Endocrine reviews 39 (2), 154-191, 2018 | 69 | 2018 |
| Thyroid ultrasound-guided fine-needle aspiration: the positive influence of on-site adequacy assessment and number of needle passes on diagnostic cytology rate EJ de Koster, JW Kist, MR Vriens, IHM Borel Rinkes, GD Valk, ... Acta cytologica 60 (1), 39-45, 2016 | 65 | 2016 |
| [18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial EJ de Koster, LF de Geus-Oei, AH Brouwers, EWCM van Dam, ... European Journal of Nuclear Medicine and Molecular Imaging, 1-15, 2022 | 30 | 2022 |
| 18F-FDG PET and 18F-FDG PET/CT in vulvar cancer: a systematic review and meta-analysis EKA Triumbari, EJ de Koster, V Rufini, SM Fragomeni, G Garganese, ... Clinical Nuclear Medicine 46 (2), 125-132, 2021 | 28 | 2021 |
| Quantitative classification and radiomics of [18F]FDG-PET/CT in indeterminate thyroid nodules EJ de Koster, WA Noortman, JM Mostert, J Booij, CB Brouwer, B de Keizer, ... European journal of nuclear medicine and molecular imaging 49 (7), 2174-2188, 2022 | 24 | 2022 |
| Is technetium-99m sestamibi imaging able to predict pathologic nonresponse to neoadjuvant chemotherapy in breast cancer? A meta-analysis evaluating current use and shortcomings A Collarino, EJ de Koster, RAV Olmos, LF de Geus-Oei, LMP Arias-Bouda Clinical breast cancer 18 (1), 9-18, 2018 | 24 | 2018 |
| FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial EJ de Koster, D Vriens, MO van Aken, LT Dijkhorst-Oei, WJG Oyen, ... European journal of nuclear medicine and molecular imaging 49 (10), 3452-3469, 2022 | 13 | 2022 |
| Health-related quality of life following FDG-PET/CT for cytological indeterminate thyroid nodules EJ de Koster, O Husson, EWCM van Dam, GS Mijnhout, RT Netea-Maier, ... Endocrine Connections 11 (8), 2022 | 5 | 2022 |
| [18F]FDG Uptake and Expression of Immunohistochemical Markers Related to Glycolysis, Hypoxia, and Proliferation in Indeterminate Thyroid Nodules EJ de Koster, ACH van Engen-van Grunsven, J Bussink, C Frielink, ... Molecular Imaging and Biology 25 (3), 483-494, 2023 | 4 | 2023 |
| A clinically applicable molecular classification of oncocytic cell thyroid nodules EJ de Koster, WE Corver, LF de Geus-Oei, WJG Oyen, D Ruano, ... Endocrine-related cancer 30 (9), 2023 | 3 | 2023 |
| 99mTc-Tilmanocept performance for sentinel node mapping in breast cancer, melanoma, and head and neck cancer: a systematic review and meta-analysis from a … G Rovera, EJ de Koster, V Rufini, M Zollino, L Zagaria, F Giammarile, ... European Journal of Nuclear Medicine and Molecular Imaging 50 (11), 3375-3389, 2023 | 3 | 2023 |
| Molecular Diagnostics and [18F]FDG-PET/CT in Indeterminate Thyroid Nodules: Complementing Techniques or Waste of Valuable Resources? EJ de Koster, H Morreau, GS Bleumink, ACH van Engen-Van Grunsven, ... Thyroid 34 (1), 41-53, 2024 | 2 | 2024 |
| Lymphatic mapping and sentinel node biopsy in vulvar melanoma: the first multicenter study and systematic review A Collarino, V Fuoco, G Garganese, T Pasciuto, EJ de Koster, A Florit, ... Gynecologic Oncology 170, 153-159, 2023 | 2 | 2023 |
| Preoperative stratification of cytologically indeterminate thyroid nodules by [18F]FDG-PET: can Orpheus bring back Eurydice? D Vriens, EJ de Koster, LF de Geus-Oei, WJG Oyen, ... European Journal of Nuclear Medicine and Molecular Imaging 50 (4), 975-979, 2023 | 1 | 2023 |
| Radioiodine in differentiated thyroid carcinoma: do we need diagnostic pre-ablation iodine-123 scintigraphy to optimize treatment? EJ de Koster, T Sulaiman, JF Hamming, A Schepers, M Snel, ... Diagnostics 11 (3), 553, 2021 | 1 | 2021 |
| Non-invasive Imaging Biomarkers of Thyroid Nodules with Indeterminate Cytology WA Noortman, EJ de Koster, FHP van Velden, LF de Geus-Oei, D Vriens Integrated Diagnostics and Theranostics of Thyroid Diseases, 63-91, 2023 | | 2023 |
| In reaction to: Thuillier P, Benisvy D, Ansquer C, Corvilain B, Mirallie E, Taieb D, et al. Section 5: What is the role of functional imaging and isotopic treatment? Ann … EJ de Koster, LF de Geus-Oei, WJG Oyen, D Vriens Annales d'endocrinologie 84 (2), 325-326, 2023 | | 2023 |
| [F-18] FDG-PET/CT and Molecular Diagnostics in the Workup of Indeterminate Thyroid Nodules: Complementing Techniques or Waste of Valuable Resources? EJ De Koster, L De Geus-Oei, H Morreau, WJG Oyen, D Vriens EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1 …, 2022 | | 2022 |
| Lioe‑Fee de Geus‑Oei1, 4, 5· Benno Kusters2· Hans Peters3· Wim JG Oyen1, 6, 7· Dennis Vriens4· On behalf of the EFFECTS trial study group EJ de Koster, ACH van Engen‑van Grunsven, J Bussink, C Frielink | | 2022 |
| Quantitative classification and radiomics of [F-18] FDG-PET/CT in indeterminate thyroid nodules M Mostert, EJ de Koster, WA Noortman, L De Geus-Oei, FH Van Velden, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 48 (SUPPL 1 …, 2021 | | 2021 |
